Foundations Investment Advisors LLC Has $10.52 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Foundations Investment Advisors LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 77.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,421 shares of the healthcare conglomerate’s stock after buying an additional 8,882 shares during the period. Foundations Investment Advisors LLC’s holdings in UnitedHealth Group were worth $10,523,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Gamco Investors INC. ET AL grew its position in UnitedHealth Group by 322.2% during the 4th quarter. Gamco Investors INC. ET AL now owns 13,194 shares of the healthcare conglomerate’s stock worth $6,625,000 after acquiring an additional 10,069 shares during the last quarter. Headinvest LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $209,000. Hoylecohen LLC boosted its position in UnitedHealth Group by 15.8% in the 4th quarter. Hoylecohen LLC now owns 1,387 shares of the healthcare conglomerate’s stock valued at $696,000 after buying an additional 189 shares during the last quarter. True North Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $3,728,000. Finally, Asset Allocation & Management Company LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $452,000. 87.25% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,273 shares of UnitedHealth Group stock in a transaction dated Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total value of $635,227.00. Following the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The disclosure for this sale can be found here. Insiders sold 140,324 shares of company stock worth $75,086,185 in the last quarter. Corporate insiders own 0.40% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $521.02 on Friday. The business’s 50-day moving average price is $529.29 and its two-hundred day moving average price is $511.63. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company has a market capitalization of $487.35 billion, a price-to-earnings ratio of 27.21, a P/E/G ratio of 1.63 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. During the same quarter last year, the business posted $4.70 EPS. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be issued a $1.65 dividend. This represents a $6.60 annualized dividend and a dividend yield of 1.27%. The ex-dividend date is Friday, September 9th. UnitedHealth Group’s payout ratio is 34.46%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Morgan Stanley increased their price objective on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Argus raised their price target on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research report on Monday, July 25th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday, September 8th. UBS Group raised their price target on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research report on Thursday, July 21st. Finally, Mizuho raised their price target on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $585.65.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.